Accès au site français Welcome to You buy France The french suppliers portal


twitter linkedin facebook viadeo

You buy France


ATLAB Pharma aims at developing radioimmunotherapy as a breakthrough in cancer treatment.

Radioimmunotherapy is a tumor-specific delivery system using monoclonal antibodies conjugated to radioisotopes (radio-antibodies) to target radiation to cancer cells wherever they have disseminated in the body, thus expanding the well-proven efficacy of radiotherapy from localized tumors to metastatic cancers.

ATLAB Pharma is at the forefront of developing safe and efficient radio-antibodies based on new generation therapeutic radioisotopes Lutetium-177 and Astatine-211.

ATLAB Pharma lead drug candidate, ATL101, has been shown to have a favorable safety profile and anti-tumor activity in Phase I and Phase II clinical trials in patients with castrate-resistant prostate cancer.

+ Read more


Company profile

Related activities :

Health, pharmacy, life sciences

Export area :

European Union

Local presence :

European Union

Target countries :

European Union

North America

North Asia

More information










Business France contributes to the development and success of French and foreign businesses wishing to expand abroad by supporting them throughout the lifetime of their projects, and is driven by an efficient, result-oriented working culture. > Read more


Discover the French know how:



Rail industry